Medicine and Health

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes

D. Sun, Z. Sang, et al.

This study explores the transformative potential of nanobodies in neutralizing SARS-CoV-2 variants, revealing their resistance to variants of concern and the discovery of unique neutralizing epitopes. Conducted by a talented team of researchers from the University of Pittsburgh and beyond, the findings highlight nanobodies' advantages over traditional antibodies, paving the way for innovative pan-coronavirus vaccines and therapeutics.

00:00

Playback language: English

Index

Abstract

This study investigates the effectiveness of nanobodies (Nbs) in neutralizing circulating SARS-CoV-2 variants. Researchers found that RBD Nbs are highly resistant to variants of concern (VOCs). High-resolution cryo-electron microscopy revealed three classes of potent neutralizing epitopes: Class I targets ACE2-binding sites; Class II binds conserved epitopes; and Class III recognizes unique, antibody-inaccessible epitopes. Comparisons with neutralizing antibodies highlighted the advantages of Nbs in achieving high-affinity and broad neutralization. The study suggests potential applications in designing pan-coronavirus vaccines and therapeutics.

Publisher

NATURE COMMUNICATIONS

Published On

Aug 03, 2021

Authors

Dapeng Sun, Zhe Sang, Yong Joon Kim, Yufei Xiang, Tomer Cohen, Anna K. Belford, Alexis Huet, James F. Conway, Ji Sun, Derek J. Taylor, Dina Schneidman-Duhovny, Cheng Zhang, Wei Huang, Yi Shi

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

T. Li, W. Xue, et al.

Medicine and Health

Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens

M. C. Miranda, E. Kepl, et al.

Medicine and Health

Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD

H. Ma, Y. Guo, et al.

Medicine and Health

Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity

W. Chen, A. Hajduczki, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny